What is a Dieulafoy lesion on endoscopy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is a Dieulafoy Lesion on Endoscopy

A Dieulafoy lesion is a tortuous submucosal artery that penetrates through the mucosa of the gastrointestinal tract, causing potentially massive hemorrhage from a tiny mucosal defect without underlying ulceration. 1

Endoscopic Appearance and Location

Classic Features

  • The lesion appears as an arteriole protruding through a small mucosal defect, typically without surrounding ulceration or significant mucosal abnormality 2
  • The vessel is usually 1-3 mm in diameter and may be actively spurting blood or show a visible vessel in the absence of active bleeding 1
  • The surrounding mucosa appears normal or near-normal, which makes the lesion particularly difficult to identify 2, 3

Typical Locations

  • Most commonly found in the stomach (53% of cases), usually within 6 cm of the gastroesophageal junction on the lesser curve 2, 4
  • Duodenum and jejunum account for 33% of cases 4
  • Large intestine represents 13% of cases 4
  • Can occur in the esophagus, though this is rare 5

Diagnostic Challenges

Why It's Difficult to Diagnose

  • The lesion's small size and hidden location make it a diagnostic challenge, often requiring repeated endoscopy if initial examination is negative 1, 2
  • The normal-appearing surrounding mucosa can cause the lesion to be overlooked during routine endoscopy 6, 3
  • Intermittent bleeding patterns may result in the lesion being obscured by blood or appearing inactive during examination 3

Commonly Missed Scenarios

  • Dieulafoy lesions are among the most frequently missed lesions in the upper gastrointestinal tract, along with Cameron's erosions, fundic varices, and angiectasias 7
  • Younger patients are more likely to have Dieulafoy lesions as a cause of bleeding compared to older patients 7

Clinical Significance

Presentation

  • Patients typically present with hematemesis, melena, hematochezia, or anemia, often with rapid blood loss requiring urgent intervention 4, 3
  • The bleeding can be massive and life-threatening despite the small size of the mucosal defect 6, 5
  • Mean age at presentation is approximately 58-79 years, with males more frequently affected 4, 3

Mortality Risk

  • Dieulafoy lesions are associated with very high mortality rates if not promptly identified and treated 8
  • Overall mortality ranges from 10-17%, though death directly attributable to exsanguination from the lesion occurs in a minority of cases 4, 3
  • Most deaths are related to underlying comorbidities rather than the bleeding itself 3

Imaging Characteristics

CT Angiography Findings

  • CTA can demonstrate Dieulafoy lesions, which are most conspicuous on arterial phase imaging 8, 1
  • Multiphase CT enterography may be helpful when the lesion is beyond the reach of standard endoscopy 1
  • CTA is particularly useful in hemodynamically unstable patients or when endoscopy fails to localize the bleeding source 1

References

Guideline

Management of Dieulafoy Lesion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Double Dieulafoy-like lesion in the stomach.

Surgical endoscopy, 2003

Research

Outcomes in Dieulafoy's Lesion: A 10-Year Clinical Review.

Digestive diseases and sciences, 2015

Guideline

Diagnostic Approach to Gastrointestinal Bleeding in Young Adults

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.